Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
CALL
iShares S&P 500 Growth ETF
IVW
$77.6B
| $3.93M | ﹤0.01% |
65,100
-2,200
| -3% | -$146K |
|
|
ICNC
4152
DELISTED
Iconic Sports Acquisition Corp.
ICNC
| $3.93M | ﹤0.01% |
392,796
-3,013
| -0.8% | -$30.1K |
|
4153
Schwab US TIPS ETF
SCHP
$16.2B
| $3.93M | ﹤0.01% |
+140,714
| New | +$4.08M |
|
4154
Curtiss-Wright
CW
$25.8B
| $3.92M | ﹤0.01% |
29,711
+3,251
| +12% | +$462K |
|
4155
PUT
Middleby
MIDD
$5.33B
| $3.92M | ﹤0.01% |
31,300
-5,800
| -16% | -$837K |
|
|
BNAI
4156
Brand Engagement Network
BNAI
$108M
| $3.92M | ﹤0.01% |
40,021
-34
| -0.1% | -$3.33K |
|
|
TWOA
4157
DELISTED
two
TWOA
| $3.92M | ﹤0.01% |
401,166
+609
| +0.2% | +$5.95K |
|
4158
CALL
Wyndham Hotels & Resorts
WH
$5.46B
| $3.91M | ﹤0.01% |
59,500
+8,800
| +17% | +$693K |
|
4159
CALL
Gen Digital
GEN
$17B
| $3.9M | ﹤0.01% |
177,700
+130,200
| +274% | +$3.2M |
|
4160
PUT
Icon
ICLR
$12.6B
| $3.9M | ﹤0.01% |
18,000
+200
| +1% | +$44.8K |
|
|
4161
iShares S&P 500 Growth ETF
IVW
$77.6B
| $3.9M | ﹤0.01% |
64,573
+22,663
| +54% | +$1.5M |
|
4162
BRC Group Holdings
RILY
$299M
| $3.9M | ﹤0.01% |
92,213
+84,083
| +1,034% | +$4.41M |
|
|
CPAR
4163
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
| $3.89M | ﹤0.01% |
399,733
-235,190
| -37% | -$2.29M |
|
4164
PUT
Intellia Therapeutics
NTLA
$1.67B
| $3.89M | ﹤0.01% |
75,200
-13,800
| -16% | -$701K |
|
|
CHS
4165
DELISTED
Chicos FAS, Inc.
CHS
| $3.89M | ﹤0.01% |
782,744
+199,803
| +34% | +$1.01M |
|
4166
CALL
AbCellera Biologics
ABCL
$3.49B
| $3.89M | ﹤0.01% |
364,900
+169,100
| +86% | +$1.43M |
|
4167
Allison Transmission
ALSN
$10.4B
| $3.88M | ﹤0.01% |
100,950
-109,964
| -52% | -$4.2M |
|
|
WIRE
4168
DELISTED
Encore Wire Corp
WIRE
| $3.88M | ﹤0.01% |
37,341
+88
| +0.2% | +$10.4K |
|
|
FVAM
4169
DELISTED
5:01 Acquisition Corp
FVAM
| $3.88M | ﹤0.01% |
391,976
-11
| -0% | -$109 |
|
4170
Grupo Cibest SA
CIB
$22.8B
| $3.88M | ﹤0.01% |
125,794
+84,627
| +206% | +$3.33M |
|
4171
Pulmonx
LUNG
$104M
| $3.88M | ﹤0.01% |
263,471
+85,518
| +48% | +$1.76M |
|
4172
CALL
Philips
PHG
$26.7B
| $3.88M | ﹤0.01% |
210,217
-33,239
| -14% | -$716K |
|
4173
CALL
Fox Class A
FOXA
$29B
| $3.87M | ﹤0.01% |
120,400
+34,700
| +40% | +$1.22M |
|
4174
CALL
Schrodinger
SDGR
$1.32B
| $3.87M | ﹤0.01% |
146,600
+15,800
| +12% | +$424K |
|
4175
Maravai LifeSciences
MRVI
$849M
| $3.87M | ﹤0.01% |
136,209
-298,682
| -69% | -$9.46M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.